Pfizer Inc

NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024

PFE Articles

August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector while consumer discretionary stocks weighed most heavily. WTI...
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and advice for clients, the one common theme throughout was where to find yields.
The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There were over 20 companies...
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon and crude oil...
Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.
August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set in. As it is, energy is the sole sector that trades higher late this afternoon, as...
When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.
The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give some insight into what companies it may be looking to pursue next.
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results this week.
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great total return vehicle for the rest of this year and into 2017.
July 14, 2016: Markets opened higher again Thursday after producer prices came in higher than expected for June and new claims for unemployment benefits came in lower than expected. The three major...